We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protein Receptor Controls Fat Storage

By Biotechdaily staff writers
Posted on 16 May 2003
Researchers working with a mouse model for obesity have found that when activated, the protein receptor peroxisome proliferators-activated receptor (PPARd) depleted fat deposits in the mice but that when mice lacked activated PPARd, they tended toward obesity. More...


Investigators from the Salk Institute (La Jolla, CA, USA) compared mice that had been genetically engineered to express activated PPARd with a group of normal animals. They found that mice with an activated PPARd gene weighed about 20% less than normal mice, even though both groups received the same food at the same rate. When the mice had reached a year of age, the difference in weight of the PPARd group widened, to 35% less than for the normal mice. The presence of activated PPARd also prevented mice from becoming obese when fed a high calorie diet. These findings were published in the April 18, 2003, issue of Cell.

"We have long known that excess calories are warehoused in fat tissue for future use,” explained senior author Professor Ronald M. Evans, chairman of the developmental and molecular biology department of the Salk Institute. "We also know that fat is released and consumed in times when energy is needed, such as from exercise or shivering from cold exposure. This study shows us that PPARd is an important regulator of this function. By exploiting PPARd, we hope to design drugs that can control how much fat is stored in the body.”




Related Links:
The Salk Institute

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.